Akebia Therapeutics Inc (AKBA)
SG&A Expense Growth
-7.44%
Quarterly · Period ending:
AKBA SG&A Expense Growth
Latest reported-7.44%period ending
Latest reported-7.44%period ending
AKBA Quarterly SG&A Growth (QoQ) (0.00% → -7.44%)
Latest values, visible window
High-resolution chart · PNG
AKBA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -7.4418% | |
| 16.6622% | |
| -13.0077% | |
| 12.9354% | |
| 3.1583% | |
| -6.9846% | |
| 4.3709% | |
| 0% | |
| 0% | |
| -100% | |
| 12.0035% | |
| -16.0009% | |
| 7.9152% | |
| -18.253% | |
| -3.8887% | |
| -1.0949% | |
| -27.2678% | |
| -1.0646% | |
| -3.3501% | |
| 8.9599% | |
| 2.9447% | |
| 2.5229% | |
| -1.3943% | |
| 11.923% | |
| -5.5175% | |
| -13.9343% | |
| 31.4237% | |
| -7.5346% | |
| 7.7921% | |
| -37.7896% | |
| 431.1332% | |
| -17.2276% | |
| 38.9406% | |
| 19.2547% | |
| 12.1369% | |
| -2.2737% | |
| 19.2985% | |
| -5.7943% | |
| 24.2718% | |
| -6.9102% | |
| -8.6044% | |
| -22.6335% | |
| 93.1842% | |
| 4.8827% | |
| 9.3188% | |
| -4.182% | |
| 20.5381% | |
| 26.8195% | |
| -38.2857% | |
| 24.6028% | |
| 279.1714% | |
| 18.9009% | |
| -1.6408% | |
| -47.6706% | |
| 0% |